Peter Fox

1.0k total citations
26 papers, 468 citations indexed

About

Peter Fox is a scholar working on Oncology, Pharmacology and Cancer Research. According to data from OpenAlex, Peter Fox has authored 26 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pharmacology and 6 papers in Cancer Research. Recurrent topics in Peter Fox's work include Estrogen and related hormone effects (4 papers), Cannabis and Cannabinoid Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter Fox is often cited by papers focused on Estrogen and related hormone effects (4 papers), Cannabis and Cannabinoid Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter Fox collaborates with scholars based in Australia, United Kingdom and United States. Peter Fox's co-authors include Adam Boyce, Val Gebski, Chris Brown, Sarah J. Lord, Chee Khoon Lee, Harold Hudson, Paul de Souza, Jessica A. Smith, Ahmad Mahran and Saad Amer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Peter Fox

26 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Fox Australia 9 219 98 91 75 69 26 468
Ping Zheng China 8 138 0.6× 37 0.4× 38 0.4× 69 0.9× 69 1.0× 44 480
Yong Beom Kim South Korea 19 174 0.8× 60 0.6× 67 0.7× 368 4.9× 85 1.2× 86 972
Naoko Sasamoto United States 12 163 0.7× 128 1.3× 55 0.6× 261 3.5× 67 1.0× 56 725
Omalkhair Abulkhair Saudi Arabia 12 426 1.9× 154 1.6× 138 1.5× 85 1.1× 269 3.9× 28 751
T M Mack United States 4 139 0.6× 87 0.9× 101 1.1× 58 0.8× 61 0.9× 6 697
Stefanos Zervoudis Greece 11 178 0.8× 74 0.8× 60 0.7× 104 1.4× 166 2.4× 55 665
Noel S. Weiss United States 10 346 1.6× 125 1.3× 36 0.4× 98 1.3× 168 2.4× 14 679
Adriano V. Laudico Philippines 13 397 1.8× 59 0.6× 68 0.7× 10 0.1× 92 1.3× 27 559
Tae‐Wook Kong South Korea 17 146 0.7× 46 0.5× 74 0.8× 363 4.8× 37 0.5× 72 882
Omar El Mesbahi Morocco 13 204 0.9× 51 0.5× 129 1.4× 23 0.3× 92 1.3× 58 494

Countries citing papers authored by Peter Fox

Since Specialization
Citations

This map shows the geographic impact of Peter Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fox more than expected).

Fields of papers citing papers by Peter Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fox. The network helps show where Peter Fox may publish in the future.

Co-authorship network of co-authors of Peter Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fox. A scholar is included among the top collaborators of Peter Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fox. Peter Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bero, Lisa, et al.. (2023). Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 13(5). e065719–e065719. 1 indexed citations
2.
Kirby, Adrienne, Martin R. Stockler, Annette Tognela, et al.. (2023). Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial.. Journal of Clinical Oncology. 41(16_suppl). 12019–12019. 5 indexed citations
3.
Lok, Sheau Wen, Richard de Boer, Sally Baron‐Hay, et al.. (2022). Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA). International Journal of Cancer. 152(2). 267–275. 3 indexed citations
4.
Low, Siew‐Kee, Peter Fox, Bavanthi Balakrishnar, et al.. (2020). Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio. The Breast. 54. 229–234. 4 indexed citations
5.
Fox, Peter, et al.. (2019). Primary squamous carcinoma of breast – a rare entity: report of two cases and review of the literature. Pathology. 51(5). 529–531. 2 indexed citations
6.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2019). Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?. The Breast. 46. 52–57. 9 indexed citations
7.
Lok, Sheau Wen, Richard de Boer, Gavin Marx, et al.. (2019). Demonstrating the feasibility of collecting secondary, de‐identified data on Australian patients receiving treatment as part of a Medicine Access Programme. Internal Medicine Journal. 50(1). 99–104. 2 indexed citations
8.
9.
10.
Sabanathan, Dhanusha, Alison Y. Zhang, Peter Fox, et al.. (2017). Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring. Cancer Chemotherapy and Pharmacology. 80(2). 385–393. 22 indexed citations
11.
Amer, Saad, Jessica A. Smith, Ahmad Mahran, Peter Fox, & Apostolos Fakis. (2017). Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction. 32(8). 1631–1638. 69 indexed citations
12.
Fox, Peter, Rosemary L. Balleine, Bo Gao, et al.. (2016). Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study. Clinical Cancer Research. 22(13). 3164–3171. 64 indexed citations
13.
Cowey, C. Lance, Lisa Mahnke, Janet L. Espirito, et al.. (2016). Real-World Outcomes of Patients with Metastatic Merkel Cell Carcinoma Treated with Second-Line or Later Chemotherapy in A Community Oncology Setting in The United States. Value in Health. 19(7). A717–A717. 4 indexed citations
14.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2016). Simplified CYP2D6 metabolizer phenotype categorization of patients treated with tamoxifen: Role for endoxifen level monitoring?. Journal of Clinical Oncology. 34(15_suppl). 536–536. 1 indexed citations
15.
Alexander, Marliese, Ashish Bajel, C. J. Doecke, et al.. (2014). Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel. Internal Medicine Journal. 44(10). 1018–1026. 25 indexed citations
16.
Fox, Peter, Harold Hudson, Chris Brown, et al.. (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. British Journal of Cancer. 109(1). 147–153. 134 indexed citations
17.
Fox, Peter, Bo Gao, Bavanthi Balakrishnar, et al.. (2013). Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation.. Journal of Clinical Oncology. 31(15_suppl). 543–543. 2 indexed citations
18.
Fox, Peter, Mark D. Chatfield, Jane Beith, et al.. (2012). Factors delaying chemotherapy for breast cancer in four urban and rural oncology units. ANZ Journal of Surgery. 83(7-8). 533–538. 11 indexed citations
19.
Ritchie, Angus, et al.. (2002). The Medical Students' Aid Project: building partnerships with the developing world. The Medical Journal of Australia. 177(11). 641–643. 1 indexed citations
20.
Fox, Peter & Ian Selwood. (1992). The Needs of Secondary School Information Technology Co‐ordinators in the United Kingdom. Journal of Information Techology for Teacher Education. 1(2). 231–240. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Zheng Breakdown of academic impact, for papers by Yong Beom Kim Breakdown of academic impact, for papers by Naoko Sasamoto Breakdown of academic impact, for papers by Omalkhair Abulkhair Breakdown of academic impact, for papers by T M Mack Breakdown of academic impact, for papers by Stefanos Zervoudis Breakdown of academic impact, for papers by Noel S. Weiss Breakdown of academic impact, for papers by Adriano V. Laudico Breakdown of academic impact, for papers by Tae‐Wook Kong Breakdown of academic impact, for papers by Omar El Mesbahi
Rankless by CCL
2026